top of page



Patient-derived tumor organoids preserve the mutational landscape and heterogeneity of the original tumor -- the first step towards 'patient-in-the-well models


  • Single organoid & whole-well read-out

  • Viability and growth rate 

  • Migration and invasion

  • Kinetic and endpoint

  • Cytostatic vs cytotoxic drug response

  • Sub-clonal response dynamics

  • Next-gen drug metrics (NDR)

  • More...

High assay performance 

Reproducible analysis

Single-organoid resolution

Account for heterogeneity

Correlation to patient response

Increase clinical relevance

Learn more about our software,

read our latest publication

bottom of page